Abstract:A liver transplant (LT) is the only curative intervention for patients with end-stage liver disease. Although significant strides have been made in post-LT care over the past 2 decades, disparities and inequities in liver disease outcomes and access to LT have been serious concerns among the hepatology and transplant communities. In early 2020, the United Network of Organ Sharing and the Organ Procurement Transplant Network (OPTN) instated the acuity circles policy to mitigate potential geographic disparities associated with LT. In a survey of leaders of LT centers, 63% of participants responded that the acuity circles system decreased wait times for patients with a Model for End-Stage Liver Disease (MELD) score of lower than 30. Approximately 75% of participants responded that the mean cost per transplant increased, likely owing to traveling a significant distance for organ procurement, whereas graft survival remained constant. However, objective data surrounding the outcomes of acuity circles in terms of waiting list mortality and access to LT remain limited. 1 In this issue of JAMA Open Network , Rinella et al 2 seek to assess the variability in liver disease mortality over time and across state lines. The study's main objective was to assess state-wide and national differences in liver-related mortality in a cross-sectional analysis of data from 2018 and 2021, evaluating both transplant-related data obtained from the Scientific Registry for Transplant Recipients and data of cause of death available from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research database. Liver-related mortality (LRM) was defined as a cause-of-death diagnostic code consistent with underlying liver disease. The authors found an overall increase in LRM from 2018 (23.6 per 100 000 individuals) to 2021 (28.1 per 100 000 individuals), with a more than 4-fold variation between states present in 2021 regardless of waiting list rates. States with low LRM had both the highest rates of out-of-state donation and the greatest chance that an in-state donation would remain within state lines. In contrast, the highest LRM states rarely retained in-state donor organs, with almost 3 in 4 eligible organs ultimately leaving the state for transplant elsewhere, and were predominately states without an in-state transplant center. This study shows, in line with prior studies, that proximity to and volume of available transplant centers continue to play a role in access to LT. 3 This study acknowledges that differences in LRM are multifactorial, and there are several nonmedical aspects to consider specific to an organ transplant. For example, the success and stability of a transplant program is contingent on its outcomes. Outcome metrics for each center are a function of total transplant volume in relation to each patient's posttransplant course, such that smaller programs have limited room for error. When transplant programs have poor outcomes, their ability to retain contracts with insurance companies for continued provision of transplant care can be affected. Therefore, because of the compensation model for transplant and the programmatic risks associated with certain cases, smaller centers may be more risk averse regarding what organs and which patients they will accept, whereas larger centers may have more flexibility and thus can afford to take on more medically or surgically complex cases. The aggressiveness of a transplant program is variable and dynamic over time, and detecting this nuance and accounting for it in any transplant policy are nearly impossible. Additionally, marginal organs can potentially be rescued from being discarded through technologies such as machine perfusion. In theory, these machines increase organ availability, but because of their high costs, this is only true for those programs that can afford to pay for these services. An additional layer to consider is that medical complexity often varies by recipient insurance coverage. Medicaid, as a state-determined health care benefit, varies in coverage for transplants across state lines, especially for certain disease conditions (such as alcohol-associated liver disease). Although Medicaid expansion through the Affordable Care Act increased access to waiting lists for LT, patients with public insurance continue to have poorer waiting list outcomes as well as increased posttransplant mortality. 4 ,5 The cause of this is likely multifaceted and likely more related to systemic issues for patients with public insurance, such as access to routine preventive medical care, as well as other social drivers of health that can affect these populations. Given the persistent issues with access to LT and equitable organ allocation, the OPTN has recently put forth a proposal currently out for public comment regarding an upcoming change t -Abstract Truncated-

Disparities in Outcomes of Liver-Related Waiting List for Transplant

Current Burden of and Geographic Disparities in Liver Mortality and Access to Liver Transplant

Liver Transplant Costs and Activity After United Network for Organ Sharing Allocation Policy Changes

Differences in Access to Liver Transplantation: Disease Severity, Waiting Time, and Transplantation Center Volume

OPTN/SRTR 2022 Annual Data Report: Liver

The rising cost of liver transplantation in the United States

Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death

Geographic Disparities in Access to Liver Transplant for Advanced Cirrhosis: Time to Ring the Alarm!

Future of U.S. living donor liver transplant: Donor and recipient criteria, transplant indications, transplant oncology, liver paired exchange, and non-directed donor graft allocation

No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD Era

A Survey of Transplant Providers Regarding Attitudes, Barriers, and Facilitators to Living Donor Liver Transplantation in the United States.

Recipient Survival among Living Donor vs. Deceased Donor Liver Transplants for Acute Liver Failure in the United States

Changing landscape of liver transplant in the United States- time for a new innovative way to define and utilize the "non-standard liver allograft"-a proposal

Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy

The Spread Pattern of New Practice in Liver Transplantation in the United States

Risk and Reward: Nationwide Analysis of Cardiac Transplant Center Variation in Organ Travel Distance and the Effects on Outcomes

Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment

Barriers to liver transplant referral in safety net settings: A national provider survey

Living Donor Availability Improves Patient Survival in a North American Center

Split Liver Transplantation and Pediatric Waitlist Mortality in the United States: Potential for Improvement

Frequency of Whole-Organ in Lieu of Split-Liver Transplantation over the Last Decade: Children Experienced Increased Wait Time and Death